Ownership and insider activity for Radiopharm Theranostics Limited (RADX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions.
Price
| Price | $1.67 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | AU |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $27.0M | $11.7M | $18.6M | $29.1M | $4.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | $56482 | $4.5M | $987413 | $10.4M | $17.4M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $27.3M | $16.3M | $22.8M | $39.9M | $21.9M |
| Property, Plant & Equipment | $1578 | $68330 | $60797 | $53466 | $46138 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $56.1M | $58.5M | $49.1M | $46.6M | 0 |
| Total Assets | $83.4M | $74.9M | $72.0M | $86.5M | $60.1M |
| Accounts Payable | $1.2M | $3.0M | $6.4M | $6.3M | $5.5M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $7.9M | $13.2M | $17.6M | $14.9M | $18.9M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $20.4M | $29.4M | $44.7M | $43.6M | $37.8M |
| Retained Earnings | -$30.8M | -$65.4M | -$111.3M | -$145.7M | -$199.7M |
| Total Equity | $63.0M | $44.4M | $28.1M | $44.8M | $24.7M |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -$27.0M | -$11.7M | -$18.6M | -$29.1M | -$4.1M |
| Working Capital | $19.4M | $3.1M | $5.3M | $24.9M | $3.0M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 1.16 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.76 |
Profitability
| Return on Equity | -218.50% |
| Return on Invested Capital | -161.91% |
| Return on Assets | -89.70% |
| Gross Margin | -77.67% |
| Operating Margin | -2468.62% |
| Net Margin | -1992.46% |
Related companies: ADXN · BCLI · CDIO · CYCN · IBO · KTTA · MTNB
Explore sector: Healthcare · Biotechnology
More sections of RADX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks